SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026534
Filing Date
2021-05-11
Accepted
2021-05-11 16:05:49
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20210331.htm 10-Q 1256920
2 EX-10.2 abio-ex102_75.htm EX-10.2 145005
3 EX-31.1 abio-ex311_7.htm EX-31.1 8576
4 EX-31.2 abio-ex312_6.htm EX-31.2 8579
5 EX-32.1 abio-ex321_8.htm EX-32.1 11227
6 GRAPHIC gneflb3r2gmg000002.jpg GRAPHIC 202155
7 GRAPHIC gubvrvugbnha000001.jpg GRAPHIC 1063
8 GRAPHIC gneflb3r2gmg000001.jpg GRAPHIC 24115
  Complete submission text file 0001564590-21-026534.txt   3844765

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT abio-20210331.xml EX-101.INS 460726
10 XBRL TAXONOMY EXTENSION SCHEMA abio-20210331.xsd EX-101.SCH 28998
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20210331_cal.xml EX-101.CAL 28546
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20210331_def.xml EX-101.DEF 66445
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20210331_lab.xml EX-101.LAB 248518
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20210331_pre.xml EX-101.PRE 174568
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 21911260
SIC: 2835 In Vitro & In Vivo Diagnostic Substances